Josephine McAuliffe
Overview
Explore the profile of Josephine McAuliffe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
978
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karron R, Talaat K, Luke C, Callahan K, Thumar B, Dilorenzo S, et al.
Vaccine
. 2009 Jun;
27(36):4953-60.
PMID: 19540952
Background: Development of live attenuated influenza vaccines (LAIV) against avian viruses with pandemic potential is an important public health strategy. Methods And Findings: We performed open-label trials to evaluate the...
2.
Karron R, Callahan K, Luke C, Thumar B, McAuliffe J, Schappell E, et al.
J Infect Dis
. 2009 Feb;
199(5):711-6.
PMID: 19210163
Development of live attenuated influenza vaccines (LAIV) against avian strains with pandemic potential is an important public-health strategy. Either 1 or 2 10(7)-TCID(50) doses of H9N2 LAIV A/chicken/Hong Kong/G9/97 were...
3.
Joseph T, McAuliffe J, Lu B, Vogel L, Swayne D, Jin H, et al.
Virology
. 2008 Jul;
378(1):123-32.
PMID: 18585748
The appearance of human infections caused by avian influenza A H7 subtype viruses underscores their pandemic potential and the need to develop vaccines to protect humans from viruses of this...
4.
Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model
Joseph T, McAuliffe J, Lu B, Jin H, Kemble G, Subbarao K
J Virol
. 2007 Jul;
81(19):10558-66.
PMID: 17634234
Avian influenza A H7 subtype viruses pose a significant threat to human health because of their ability to transmit directly from domestic poultry to humans and to cause disease and,...
5.
Suguitan Jr A, McAuliffe J, Mills K, Jin H, Duke G, Lu B, et al.
PLoS Med
. 2006 Sep;
3(9):e360.
PMID: 16968127
Background: Recent outbreaks of highly pathogenic influenza A H5N1 viruses in humans and avian species that began in Asia and have spread to other continents underscore an urgent need to...
6.
McAuliffe J, Vogel L, Roberts A, Fahle G, Fischer S, Shieh W, et al.
Virology
. 2004 Nov;
330(1):8-15.
PMID: 15527829
SARS coronavirus (SARS-CoV) administered intranasally and intratracheally to rhesus, cynomolgus and African Green monkeys (AGM) replicated in the respiratory tract but did not induce illness. The titer of serum neutralizing...
7.
Prentice E, McAuliffe J, Lu X, Subbarao K, Denison M
J Virol
. 2004 Aug;
78(18):9977-86.
PMID: 15331731
The severe acute respiratory syndrome coronavirus (SARS-CoV) encodes proteins required for RNA transcription and genome replication as large polyproteins that are proteolytically processed by virus-encoded proteinases to produce mature replicase...
8.
Subbarao K, McAuliffe J, Vogel L, Fahle G, Fischer S, Tatti K, et al.
J Virol
. 2004 Mar;
78(7):3572-7.
PMID: 15016880
Following intranasal administration, the severe acute respiratory syndrome (SARS) coronavirus replicated to high titers in the respiratory tracts of BALB/c mice. Peak replication was seen in the absence of disease...
9.
Bukreyev A, Skiadopoulos M, McAuliffe J, Murphy B, Collins P, Schmidt A
Proc Natl Acad Sci U S A
. 2002 Dec;
99(26):16987-91.
PMID: 12482928
New or improved vaccines against viruses such as influenza, parainfluenza types 1-3, measles, dengue, and respiratory syncytial virus would prevent an enormous burden of morbidity and mortality. Vaccines or vaccine...